Recent News

Physicians issue advice, raise questions about best practices for evaluating blood in the urine as a sign of cancer

Physicians issue advice, raise questions about best practices for evaluating blood in the urine as a sign of cancer

A new report from the American College of Physicians’ High Value Care Task Force issues advice for physicians on how to detect and evaluate blood found in the urine, which is known as hematuria. The report, which was first-authored by UNC Lineberger Comprehensive Cancer Center member Dr. Matthew Nielsen, also raises questions about the potential harms associated with diagnostic tests that are commonly employed to evaluate this condition.

Physicians issue advice, raise questions about best practices for evaluating blood in the urine as a sign of cancer - Read More…

UNC Lineberger joins nation’s cancer centers in endorsement of HPV vaccination for cancer prevention

UNC Lineberger joins nation’s cancer centers in endorsement of HPV vaccination for cancer prevention

UNC Lineberger Comprehensive Cancer Center has joined 68 of the nation's top cancer centers in urging increased vaccination for the human papillomavirus, or HPV. Recognizing insufficient vaccination rates present a public health threat, this nationwide network of experts is calling upon physicians, parents and young adults to take advantage of this rare opportunity to prevent many types of cancer.

UNC Lineberger joins nation’s cancer centers in endorsement of HPV vaccination for cancer prevention - Read More…

Study finds need for improved end-of-life care for parents with terminal cancer

Study finds need for improved end-of-life care for parents with terminal cancer

Based on a survey of widowed fathers who had lost a spouse to cancer, UNC Lineberger researchers reported in the journal BMJ Palliative Care that additional research and improved end-of-life care are needed to specifically help dying parents as well as their families.

Study finds need for improved end-of-life care for parents with terminal cancer - Read More…

Nanoparticle form of bone loss prevention drug effective against cancer, preclinical study finds

Nanoparticle form of bone loss prevention drug effective against cancer, preclinical study finds

A preclinical study led by a UNC Lineberger researcher found that a nanoparticle form of a drug used to prevent bone loss was effective against small-cell lung and prostate cancer cells. The results were published in the journal Biomaterials.

Nanoparticle form of bone loss prevention drug effective against cancer, preclinical study finds - Read More…